Research library

Key finding

The study reports that increased synthesis of NAD+ promotes protective cell responses, further demonstrating that NAD+ is a regulatory molecule associated with several biochemical pathways.

Key finding

The study reports that in addition, delayed microglial activation normally seen after TBI was reduced by NAD⁺ treatment at 7 days after insult.

Key finding

The study reports that the NAD+ administration also significantly attenuated ischemia-induced neurological deficits.

Key finding

The study reports that advancing age and many disease states are associated with declines in nicotinamide adenine dinucleotide (NAD+) levels.

Key finding

The study reports that many of these ageing-associated diseases can be slowed down and even reversed by restoring NAD+ levels.

Key finding

The study reports that here we review factors that regulate NAD(+) and discuss how supplementation with NAD(+) precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.

Key finding

The study reports that thus, the combination of sirtuin activation and NAD(+) intermediate supplementation may be an effective antiaging intervention, providing hope to aging societies worldwide.

Key finding

12 wk of NR supplementation in doses of 2000 mg/d appears safe, but does not improve insulin sensitivity and whole-body glucose metabolism in obese, insulin-resistant men.

Key finding

The study reports that we suggest that these early findings provide the rationale for adequately powered randomized trials to evaluate the efficacy of NAD+ augmentation as a therapeutic strategy to prevent and treat metabolic disorders and age-related conditions.

Key finding

The study reports that as the NAD+ concentration in human skin, blood, liver, muscle, and brain are thought to decrease with age, finding ways to increase NAD+ status could possibly influence the aging process and associated metabolic sequelae.